Tremfya

Tremfya (guselkumab) is a prescription medication used to treat moderate to severe plaque psoriasis and psoriatic arthritis. This biologic therapy targets specific immune pathways to reduce inflammation and skin symptoms. Always consult a healthcare provider before use.

Tremfya is primarily used to manage moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is also approved for active psoriatic arthritis, helping to reduce joint pain, swelling, and skin lesions. Patients often ask, 'what is guselkumab used for' to understand its role in treating these chronic conditions.

Many patients experience reduced redness, scaling, and thickness of psoriatic plaques after starting Tremfya. For psoriatic arthritis, it may help improve joint function and decrease morning stiffness. Individual responses vary, and visible improvements often develop gradually over weeks.

Tremfya should be stored refrigerated and protected from light until use. Before administration, check the solution for particles or discoloration. Keep out of reach of children and pets. Discard used pens or syringes properly according to local guidelines.

Live vaccines should be avoided during and shortly after Tremfya treatment due to potential immune response interference. Patients on immunosuppressive therapies should discuss timing with their doctor. No specific food interactions are known, but always inform your healthcare provider about all medications.